7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hemangioma, Capillary D018324 1 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Prediabetic State D011236 1 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Rheumatic Fever D012213 1 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Hemarthrosis D006395 1 associated lipids
Cherubism D002636 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Emphysema D004646 1 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Ankylosis D000844 1 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Prosthesis Failure D011475 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Foot Injuries D018409 1 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Periostitis D010522 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Osteopetrosis D010022 1 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Tooth Resorption D014091 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Atrial Remodeling D064752 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Hyperostosis D015576 1 associated lipids
Hip Dislocation D006617 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Actinomycosis D000196 2 associated lipids
Hip Fractures D006620 2 associated lipids
Fractures, Stress D015775 2 associated lipids
Osteosclerosis D010026 2 associated lipids
Osteophyte D054850 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Pericardial Effusion D010490 2 associated lipids
Lymphocytosis D008218 2 associated lipids
Radicular Cyst D011842 2 associated lipids
Gingival Recession D005889 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Tooth Migration D014085 2 associated lipids
Dengue D003715 2 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Angina, Stable D060050 2 associated lipids
Tooth Mobility D014086 2 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Microvascular Angina D017566 2 associated lipids
Otosclerosis D010040 2 associated lipids
Root Resorption D012391 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Labyrinthitis D007762 2 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Eye Neoplasms D005134 2 associated lipids
Lithiasis D020347 2 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Lu L et al. A novel therapeutic strategy for adolescent idiopathic scoliosis based on osteoporotic concept. 2013 Med. Hypotheses pmid:23562283
Fu YX et al. Osteoprotegerin influences the bone resorption activity of osteoclasts. 2013 Int. J. Mol. Med. pmid:23563320
Xu L et al. Effects of cell surface α2-3 sialic acid on osteogenesis. 2013 Glycoconj. J. pmid:23519914
Çankaya M et al. The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model. 2013 Int J Oral Maxillofac Surg pmid:23522850
Pichler K et al. RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis. 2013 Histol. Histopathol. pmid:23553492
Kwon H et al. Effect of 635 nm irradiation on high glucose-boosted inflammatory responses in LPS-induced MC3T3-E1 cells. 2013 Lasers Med Sci pmid:22699799
Tantikanlayaporn D et al. A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. 2013 Phytomedicine pmid:23557993
Rahnama M et al. Influence of hormone replacement therapy on osteoprotegerin and receptor activator of nuclear factor kappa-B ligand concentrations in menopausal women. 2013 J. Interferon Cytokine Res. pmid:23745763
Fuernau G et al. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging. 2013 Int. J. Cardiol. pmid:22704876
Rakic M et al. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. 2013 Clin Oral Implants Res pmid:22708989
Kadow-Romacker A et al. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro. 2013 J Biomater Appl pmid:21862509
Pateinakis P et al. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. 2013 BMC Nephrol pmid:23758931
Weiss RM et al. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. 2013 PLoS ONE pmid:23762316
Ding Q and Zhang FQ [Effect of icariin on the expression of receptor activator nuclear factor-κB ligand and osteoprotegerin of human periodontal ligament cells]. 2013 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23714056
Okamura H et al. Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts. 2013 FEBS Lett. pmid:23183242
Silva HC et al. Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. 2013 Bone pmid:23142805
Sivagurunathan S et al. Thrombin inhibits osteoclast differentiation through a non-proteolytic mechanism. 2013 J. Mol. Endocrinol. pmid:23419317
Stalvey MS et al. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease. 2013 PLoS ONE pmid:24236172
Zhou J et al. [Effect of osthole on bone metabolism in rat femoral tissues in vitro]. 2013 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:24183047
Jacobs C et al. Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain. 2013 Arch. Oral Biol. pmid:23422327
Joo MK et al. The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats. 2013 Mol Med Rep pmid:23426758
Tecilazich F et al. Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. 2013 J. Vasc. Surg. pmid:23465172
Loiselle AE et al. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice. 2013 PLoS ONE pmid:24260576
Ye Z et al. Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. 2013 Am. J. Hypertens. pmid:23467205
Fekete S et al. The effect of levetiracetam on rat bone mass, structure and metabolism. 2013 Epilepsy Res. pmid:24035343
He T et al. Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty. 2013 Int Orthop pmid:23467893
Song JF et al. Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women. 2013 Genet. Mol. Res. pmid:24065669
Lin C et al. The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. 2013 PLoS ONE pmid:23469146
Yu F et al. Association between osteoprotegerin genetic variants and osteoporosis in Chinese postmenopausal women. 2013 Endocr. J. pmid:24067544
Wu LZ et al. Nicotine favors osteoclastogenesis in human periodontal ligament cells co-cultured with CD4(+) T cells by upregulating IL-1β. 2013 Int. J. Mol. Med. pmid:23443505
Nishigaki M et al. β-cryptoxanthin regulates bone resorption related-cytokine production in human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:23452546
Bao X et al. The effect on proliferation and differentiation of cementoblast by using sclerostin as inhibitor. 2013 Int J Mol Sci pmid:24152444
Prati AJ et al. Release of bone markers in immediately loaded and nonloaded dental implants: a randomized clinical trial. 2013 J. Dent. Res. pmid:24158337
de Araújo Júnior RF et al. Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. 2013 PLoS ONE pmid:23843954
Kim HR et al. Serum osteoprotegerin level is associated with degree of arteriovenous fistula stenosis in patients with hemodialysis. 2013 Clin. Nephrol. pmid:24091316
Xiong Q et al. [Effects of recombinant human osteoprotegerin and recombinant RANK protein on the differentiation of osteoclast precursors]. 2013 Zhongguo Gu Shang pmid:23844495
Kovács G et al. [Metabolic differences in healthy first-degree female relatives of type 2 diabetic patients]. 2013 Orv Hetil pmid:24161599
Zhang PF et al. Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis. 2013 COPD pmid:23845033
Jiang W et al. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays. 2013 PLoS ONE pmid:24116163
Riesco M et al. Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. 2013 Clin. Rheumatol. pmid:23846386
Canalis E et al. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. 2013 J. Biol. Chem. pmid:23884415
Szymczak J and Bohdanowicz-Pawlak A Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. 2013 Horm. Metab. Res. pmid:23888411
Gordin D et al. Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. 2013 Diabetes Care pmid:23801795
Fu YX et al. Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions. 2013 J. Vet. Sci. pmid:23820214
Wulf-Johansson H et al. Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions. 2013 PLoS ONE pmid:24349233
Nehring P et al. Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex‑specific rs2073618 polymorphism as a risk factor for diabetic foot. 2013 Pol. Arch. Med. Wewn. pmid:23299915
Kim JY et al. Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress. 2013 Arthritis Rheum. pmid:23666878
Marano RJ et al. Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. 2013 PLoS ONE pmid:23667691
Galeone A et al. Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 2013 Eur J Cardiothorac Surg pmid:23671202
Xi L et al. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. 2013 Cardiology pmid:23295350
Steinmetz M et al. Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization. 2013 J. Mol. Cell. Cardiol. pmid:23295770
Eleftheriadis T et al. Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients. 2013 Int Urol Nephrol pmid:23296793
dos Santos PL et al. Guided implant surgery: what is the influence of this new technique on bone cell viability? 2013 J. Oral Maxillofac. Surg. pmid:23298799
Hoy J et al. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. 2013 J. Bone Miner. Res. pmid:23299909
Yassuda DH et al. Magnesium incorporation into β-TCP reduced its in vivo resorption by decreasing parathormone production. 2013 J Biomed Mater Res A pmid:23239606
Kuriwaka-Kido R et al. Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess. 2013 Endocrinology pmid:23397032
Manfrin TM et al. Expression of OPG, RANK, and RANKL proteins in tooth repair processes after immediate and delayed tooth. 2013 J Craniofac Surg pmid:23348347
Zhou J et al. Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats. 2013 Rheumatol. Int. pmid:22948539
Saito K et al. Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. 2013 PLoS ONE pmid:23349978
Keller KK et al. SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes. 2013 Rheumatol. Int. pmid:22948540
Kelesidis T et al. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. 2013 AIDS Res. Hum. Retroviruses pmid:23351153
Jimi E et al. The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma (Review). 2013 Int. J. Oncol. pmid:23354319
Kebschull M et al. Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen. 2013 PLoS ONE pmid:23355901
Velusamy SK et al. Lactoferrin knockout mice demonstrates greater susceptibility to Aggregatibacter actinomycetemcomitans-induced periodontal disease. 2013 J. Periodontol. pmid:23327622
Gümüş P et al. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease. 2013 J. Periodontol. pmid:23327689
Rosenheck S The heart and the osteoclasts. 2013 Cardiology pmid:23328209
Frederiksen L et al. Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat. 2013 Horm. Metab. Res. pmid:22918704
Pei Z et al. Effect of icariin on cell proliferation and the expression of bone resorption/formation-related markers in human periodontal ligament cells. 2013 Mol Med Rep pmid:24065204
Olivares-Navarrete R et al. Rough titanium alloys regulate osteoblast production of angiogenic factors. 2013 Spine J pmid:23684238
Ney JT et al. Genetic polymorphism of the OPG gene associated with breast cancer. 2013 BMC Cancer pmid:23369128
Milone F et al. Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases. 2013 Biomarkers pmid:23336103
Cao H et al. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. 2013 Int. J. Cardiol. pmid:22178057
Zhang ZG et al. Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats. 2013 Menopause pmid:23096243
Bosselut N et al. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy. 2013 Clin. Chim. Acta pmid:23022619
Nanjundaiah SM et al. Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. 2013 Jan-Mar Int J Immunopathol Pharmacol pmid:23527707
Esteghamati A et al. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23877020
Glintborg D et al. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23211475
Zamora PO et al. Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. 2013 Mar-Apr Int. J. Toxicol. pmid:23422080
Horshuns'ka MIu et al. [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. 2013 May-Jun Ukr Biokhim Zh (1999) pmid:23937044
Canto-Cetina T et al. Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. 2013 Nov-Dec Am. J. Hum. Biol. pmid:24130145
Liu S et al. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. 2013 Oct-Dec Hormones (Athens) pmid:24457406
Chiang PH et al. Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. 2013 Oct-Dec J Cancer Res Ther pmid:24518712
Marques EA et al. Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. 2013 Sep-Oct Arch Gerontol Geriatr pmid:23623588
Bjerre M et al. Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. 2014 Scand. J. Clin. Lab. Invest. pmid:25026506
Tang ZL et al. An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone. 2014 J. Oral Maxillofac. Surg. pmid:24071373
Nakashima T [Coupling and communication between bone cells]. 2014 Clin Calcium pmid:24870836
Shimamura M et al. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24847069
Ghorbanihaghjo A et al. Osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in exudative age-related macular degeneration. 2014 Acta Med Iran pmid:24901855
Dessein PH et al. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. 2014 J. Rheumatol. pmid:24488413
Davaine JM et al. Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. 2014 PLoS ONE pmid:25259713
Zhang Z et al. High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio. 2014 Int J Mol Sci pmid:25257532
Pullisaar H et al. Simvastatin coating of TiOâ‚‚ scaffold induces osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells. 2014 Biochem. Biophys. Res. Commun. pmid:24704451
Chaganti RK et al. Elevation of serum tumor necrosis factor α in patients with periprosthetic osteolysis: a case-control study. 2014 Clin. Orthop. Relat. Res. pmid:24307062
Simpson CA et al. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5. 2014 Osteoporos Int pmid:24927689
Fuernau G et al. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. 2014 Eur. J. Heart Fail. pmid:24903195
Inubushi T et al. Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis. 2014 Arch. Oral Biol. pmid:24370195
Huang JW et al. Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. 2014 Nutr Metab Cardiovasc Dis pmid:24361071
Pobeha P et al. Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD. 2014 Respir Med pmid:24424018
Kinney JS et al. Crevicular fluid biomarkers and periodontal disease progression. 2014 J. Clin. Periodontol. pmid:24303954
Chauvat A et al. Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans. 2014 Hum Vaccin Immunother pmid:24084262

Table of Content